Alaunos Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Alaunos Therapeutics, Inc.‘s stocks are currently a part of 71 hedge funds’ portfolios, which represents 6.14% of the total amount of its stocks outstanding. This makes up a total of 13.32M shares of Alaunos Therapeutics, Inc.. Compared to the previous quarter, the number fell by -82.82% or -64.22M shares fewer. As for the holding position changes, 18.31% (13) of current hedge fund investors increased the number of shares held, 25.35% (18) of current holders sold a part of the shares held, and 15.49% (11) closed the holdings completely. 4 hedge funds are new holders of Alaunos Therapeutics, Inc. stock in Q1 2023, it is 5.63% of total holders.
Hedge funds holding Alaunos Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 131 |
|---|---|
| Q3 2018 | 131 |
| Q4 2018 | 131 |
| Q1 2019 | 121 |
| Q2 2019 | 139 |
| Q3 2019 | 140 |
| Q4 2019 | 145 |
| Q1 2020 | 140 |
| Q2 2020 | 143 |
| Q3 2020 | 150 |
| Q4 2020 | 152 |
| Q1 2021 | 150 |
| Q2 2021 | 153 |
| Q3 2021 | 161 |
| Q4 2021 | 160 |
| Q1 2022 | 138 |
| Q2 2022 | 116 |
| Q3 2022 | 121 |
| Q4 2022 | 119 |
| Q1 2023 | 71 |
Hedge funds changes in Alaunos Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 14 | 36 | 38 | 13 | 30 |
|---|---|---|---|---|---|
| Q3 2018 | 16 | 32 | 36 | 16 | 31 |
| Q4 2018 | 24 | 36 | 40 | 24 | 7 |
| Q1 2019 | 12 | 38 | 27 | 22 | 22 |
| Q2 2019 | 30 | 49 | 25 | 10 | 25 |
| Q3 2019 | 23 | 49 | 32 | 22 | 14 |
| Q4 2019 | 26 | 46 | 35 | 20 | 18 |
| Q1 2020 | 23 | 52 | 32 | 25 | 8 |
| Q2 2020 | 18 | 59 | 33 | 14 | 19 |
| Q3 2020 | 23 | 43 | 46 | 18 | 20 |
| Q4 2020 | 26 | 39 | 52 | 24 | 11 |
| Q1 2021 | 20 | 54 | 39 | 20 | 17 |
| Q2 2021 | 23 | 47 | 44 | 19 | 20 |
| Q3 2021 | 25 | 65 | 33 | 18 | 20 |
| Q4 2021 | 24 | 49 | 53 | 23 | 11 |
| Q1 2022 | 16 | 30 | 39 | 36 | 17 |
| Q2 2022 | 23 | 20 | 40 | 43 | -10 |
| Q3 2022 | 22 | 34 | 29 | 17 | 19 |
| Q4 2022 | 26 | 22 | 30 | 27 | 14 |
| Q1 2023 | 4 | 13 | 18 | 11 | 25 |
Hedge funds changes in Alaunos Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 1,167,100 | 2,358,000 |
|---|---|---|
| Q3 2018 | 1,030,000 | 1,662,000 |
| Q4 2018 | 1,540,850 | 2,105,000 |
| Q1 2019 | 4,355,000 | 3,737,000 |
| Q2 2019 | 6,058,000 | 6,889,000 |
| Q3 2019 | 4,111,000 | 4,000,000 |
| Q4 2019 | 2,058,000 | 6,377,000 |
| Q1 2020 | 2,781,199 | 2,718,087 |
| Q2 2020 | 3,315,000 | 2,353,000 |
| Q3 2020 | 1,465,000 | 1,860,000 |
| Q4 2020 | 1,392,000 | 1,831,000 |
| Q1 2021 | 2,698,000 | 2,092,000 |
| Q2 2021 | 1,939,000 | 1,802,000 |
| Q3 2021 | 15,138,000 | 1,067,000 |
| Q4 2021 | 801,000 | 359,000 |
| Q1 2022 | 203,000 | 99,000 |
| Q2 2022 | 343,000 | 232,000 |
| Q3 2022 | 13,943,000 | 756,000 |
| Q4 2022 | 5,147,174 | 204,483 |
| Q1 2023 | 0 | 0 |